New diabetes drug HDM1005 enters final testing phase
NCT ID NCT07394114
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 3 trial is testing whether the experimental drug HDM1005 can help people with type 2 diabetes control their blood sugar better than a placebo. About 240 adults who have not used diabetes medication for at least 12 weeks will receive either HDM1005 or a placebo injection weekly for up to 52 weeks. The main goal is to see if HDM1005 lowers HbA1c, a key measure of long-term blood sugar control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HDM1005 (an injectable drug for blood sugar control)
- What this could lead to
- If successful, HDM1005 could offer a new treatment option to help people with type 2 diabetes better manage their blood sugar levels.
- What could go wrong
- This is a Phase 3 trial, but it is still testing a new drug. It may not prove more effective than existing treatments, and side effects are possible. Results may not apply to all diabetes patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chinese PLA General Hospital
RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Personality type may influence diabetic wound healing – a study investigates
- Can a strong support network help people with diabetic kidney disease take better care of themselves?
- Eye scan may spot hidden blood-flow changes that signal glaucoma risk in diabetes
- Tight glucose control may preserve insulin-making cells in type 2 diabetes
- A quick finger-prick test could spot hidden diabetes in rural villages
- Could chickpea flour bread tame blood sugar spikes?